197 related articles for article (PubMed ID: 28123885)
1. Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients.
Nonomura Y; Otsuka A; Nakashima C; Seidel JA; Kitoh A; Dainichi T; Nakajima S; Sawada Y; Matsushita S; Aoki M; Takenouchi T; Fujimura T; Hatta N; Koreeda S; Fukushima S; Honda T; Kabashima K
Oncoimmunology; 2016; 5(12):e1248327. PubMed ID: 28123885
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.
Kubo Y; Fukushima S; Inamori Y; Tsuruta M; Egashira S; Yamada-Kanazawa S; Nakahara S; Tokuzumi A; Miyashita A; Aoi J; Kajihara I; Tomita Y; Wakamatsu K; Jinnin M; Ihn H
J Dermatol Sci; 2019 Jan; 93(1):33-40. PubMed ID: 30318169
[TBL] [Abstract][Full Text] [Related]
3. Th9 cells are subjected to PD-1/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer.
Wang C; Lu Y; Chen L; Gao T; Yang Q; Zhu C; Chen Y
Int Immunopharmacol; 2020 Jan; 78():106019. PubMed ID: 31776089
[TBL] [Abstract][Full Text] [Related]
4. Potential clinical implications of CD4
Galati D; Zanotta S; Capone M; Madonna G; Mallardo D; Romanelli M; Simeone E; Festino L; Sparano F; Azzaro R; De Filippi R; Pinto A; Paulos CM; Ascierto PA
J Transl Med; 2023 May; 21(1):318. PubMed ID: 37170241
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of interleukin-9 ameliorates symptoms of allergic rhinitis by reducing Th2, Th9, and Th17 responses and increasing the Treg response in a murine model.
Gu ZW; Wang YX; Cao ZW
Oncotarget; 2017 Feb; 8(9):14314-14324. PubMed ID: 28187441
[TBL] [Abstract][Full Text] [Related]
6. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
[TBL] [Abstract][Full Text] [Related]
7. [Role of Th9, Th17, Treg Cells levels and IL-9, IL-17 and TGF-β Expression in Peripheral Blood of Patients with ITP in Pathogenesis of ITP].
Zhou ZJ; Zhang YS; Liang CX; Yang ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):180-184. PubMed ID: 30738467
[TBL] [Abstract][Full Text] [Related]
8. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM; Freeman GJ; McDermott DF
Clin Ther; 2015 Apr; 37(4):764-82. PubMed ID: 25823918
[TBL] [Abstract][Full Text] [Related]
9. IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling.
Xue G; Jin G; Fang J; Lu Y
Nat Commun; 2019 Mar; 10(1):1376. PubMed ID: 30914642
[TBL] [Abstract][Full Text] [Related]
10. PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.
Dulos J; Carven GJ; van Boxtel SJ; Evers S; Driessen-Engels LJ; Hobo W; Gorecka MA; de Haan AF; Mulders P; Punt CJ; Jacobs JF; Schalken JA; Oosterwijk E; van Eenennaam H; Boots AM
J Immunother; 2012; 35(2):169-78. PubMed ID: 22306905
[TBL] [Abstract][Full Text] [Related]
11. Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro.
Tay WT; Fang YH; Beh ST; Liu YW; Hsu LW; Yen CJ; Liu PY
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244307
[TBL] [Abstract][Full Text] [Related]
12. Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade.
Bochem J; Zelba H; Amaral T; Spreuer J; Soffel D; Eigentler T; Wagner NB; Uslu U; Terheyden P; Meier F; Garbe C; Pawelec G; Weide B; Wistuba-Hamprecht K
PLoS One; 2019; 14(8):e0221301. PubMed ID: 31419253
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles.
Graves M; CelliMarchett G; van Zyl B; Tang D; Vilain RE; van der Westhuizen A; Bowden NA
Front Med (Lausanne); 2019; 6():113. PubMed ID: 31192212
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
Wu HQ; Zhao JJ; Li HW; Zhang Z
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
[No Abstract] [Full Text] [Related]
15. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
16. Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Yamaguchi K; Mishima K; Ohmura H; Hanamura F; Ito M; Nakano M; Tsuchihashi K; Ota SI; Wada N; Uchi H; Ariyama H; Kusaba H; Niiro H; Akashi K; Baba E
Cancer Sci; 2018 Oct; 109(10):3032-3042. PubMed ID: 30066977
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor Foxo1 is essential for IL-9 induction in T helper cells.
Malik S; Sadhu S; Elesela S; Pandey RP; Chawla AS; Sharma D; Panda L; Rathore D; Ghosh B; Ahuja V; Awasthi A
Nat Commun; 2017 Oct; 8(1):815. PubMed ID: 28993609
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral expression levels of
Inoue H; Park JH; Kiyotani K; Zewde M; Miyashita A; Jinnin M; Kiniwa Y; Okuyama R; Tanaka R; Fujisawa Y; Kato H; Morita A; Asai J; Katoh N; Yokota K; Akiyama M; Ihn H; Fukushima S; Nakamura Y
Oncoimmunology; 2016; 5(9):e1204507. PubMed ID: 27757299
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory dynamics of excretory and secretory products on Th9 immune response during Haemonchus contortus infection in goat.
Memon MA; Naqvi MA; Xin H; Meng L; Hasan MW; Haseeb M; Lakho SA; Aimulajiang K; Bu Y; Xu L; Song X; Li X; Yan R
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008218. PubMed ID: 32243446
[TBL] [Abstract][Full Text] [Related]
20. Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.
Yoshino K; Nakayama T; Ito A; Sato E; Kitano S
BMC Cancer; 2019 Oct; 19(1):1019. PubMed ID: 31664934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]